Suppr超能文献

血液透析血管通路:关于通路推广、障碍及未来经验教训的历史视角

Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the Future.

作者信息

Besarab Anatole, Frinak Stanley, Margassery Suresh, Wish Jay B

机构信息

Department of Medicine, Stanford University School of Medicine, Stanford, CA.

Department of Medicine, Henry Ford Health System, Detroit, MI.

出版信息

Kidney Med. 2024 Jul 15;6(9):100871. doi: 10.1016/j.xkme.2024.100871. eCollection 2024 Sep.

Abstract

This review describes the history of vascular access for hemodialysis (HD) over the past 8 decades. Reliable, repeatable vascular access for outpatient HD began in the 1960s with the Quinton-Scribner shunt. This was followed by the autologous Brecia-Cimino radial-cephalic arteriovenous fistula (AVF), which dominated HD vascular access for the next 20 years. Delayed referral and the requirement of 1.5-3 months for AVF maturation led to the development of and increasing dependence on synthetic arteriovenous grafts (AVGs) and tunneled central venous catheters, both of which have higher thrombosis and infection risks than AVFs. The use of AVGs and tunneled central venous catheters increased progressively to the point that, in 1997, the first evidence-based clinical practice guidelines for HD vascular access recommended that they only be used if a functioning AVF could not be established. Efforts to promote AVF use in the United States during the past 2 decades doubled their prevalence; however, recent practice guidelines acknowledge that not all patients receiving HD are ideally suited for an AVF. Nonetheless, improved referral for AVF placement before dialysis initiation and improved conversion of failing AVGs to AVFs may increase AVF use among patients in whom they are appropriate.

摘要

本综述描述了过去80年中血液透析(HD)血管通路的发展历程。20世纪60年代,随着Quinton-Scribner分流术的出现,门诊血液透析有了可靠、可重复的血管通路。随后是自体的Brecia-Cimino桡动脉-头静脉内瘘(AVF),在接下来的20年里,它一直是血液透析血管通路的主要方式。转诊延迟以及AVF成熟需要1.5至3个月的时间,导致了合成动静脉移植物(AVG)和带隧道的中心静脉导管的发展和使用增加,这两种方式的血栓形成和感染风险均高于AVF。AVG和带隧道的中心静脉导管的使用逐渐增加,到1997年,首个基于证据的血液透析血管通路临床实践指南建议,只有在无法建立起功能良好的AVF时才使用它们。在过去20年里,美国为推广AVF的使用做出了努力,其普及率翻了一番;然而,最近的实践指南承认,并非所有接受血液透析的患者都理想地适合使用AVF。尽管如此,在透析开始前改善AVF置入的转诊情况,以及将功能不良的AVG更好地转换为AVF,可能会增加适合使用AVF的患者的AVF使用率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fad/11364114/a8aa2a6265e7/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验